Form 4: Omnicell EVP Sells Shares Under 10b5-1 Plan

Omnicell's EVP & Chief Legal/Admin Officer, Corey J. Manley, sold 6,106 shares of common stock for $39.90 per share under a pre-arranged trading plan.

Summary

• Corey J. Manley, Executive Vice President and Chief Legal/Administrative Officer of Omnicell, Inc. (OMCL), reported the sale of 6,106 shares of common stock.
• The transaction occurred on December 3, 2025, with shares sold at a price of $39.90 each.
• This sale was executed pursuant to a Rule 10b5-1 trading plan, which Mr. Manley adopted on June 13, 2025.
• Following this transaction, Mr. Manley directly beneficially owns 98,282 shares of Omnicell common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can be perceived negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling based on non-public information. It's a routine personal financial management event for an executive.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information, which can reduce concerns about opportunistic selling.

Negatives

• An insider sale, even under a 10b5-1 plan, reduces the executive's direct ownership stake in the company.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing (Form 4) and does not provide specific industry context. Insider sales, even under 10b5-1 plans, are common across industries as executives manage personal finances and diversify portfolios.

Stakeholder Impact

• Shareholders: The sale slightly reduces the direct ownership stake of a key executive, which could be interpreted as a minor negative signal, though mitigated by the 10b5-1 plan.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider transaction.

Key Dates

Recommendation

This Form 4 filing reports a routine insider sale executed under a pre-arranged 10b5-1 trading plan. Such transactions are typically for personal financial management and diversification and do not usually signal a change in the company's fundamental outlook or the executive's confidence. Therefore, it does not provide a strong basis for a 'buy' or 'sell' recommendation, suggesting a 'hold' position for existing investors.

Keywords

Omnicell, OMCL, Corey J. Manley, insider trading, Form 4, stock sale, 10b5-1 plan, executive compensation